News

CSRF Recommends Insightful Books About Cushing’s Disease

The Cushing’s Support and Research Foundation (CSRF) is calling attention to three books of potential interest to Cushing’s Disease patients and to healthcare providers who treat the relatively rare endocrine disorder. In Cushing’s Disease, the adrenal glands release too much of the hormone cortisol into the body for long periods…

Researchers Recruiting Cushing’s Disease Patients for Osilodrostat Phase 3 Trial

A new Phase 3 clinical trial (NCT02697734) is actively recruiting Cushing’s disease patients in several countries to test the safety and effectiveness of the investigational therapy osilodrostat (LCI699). The 48-week, multicenter, randomized, double-blind, placebo-controlled study is sponsored by Novartis Pharmaceuticals. Estimated enrollment is 69 patients at 26 locations…

Cushing’s Related Tumors Require Lymph Vessel Growth for Steroid Production, Study Suggests

Aggressive adrenocortical carcinomas differ from tumors linked to Cushing’s syndrome in the density of blood and lymph vessels, according to a research team at Portugal’s University of Porto. Their study, “Angiogenesis and Lymphangiogenesis in the Adrenocortical Tumors,” appeared in the journal Pathology & Oncology Research. It offers insights into the…